Desvenlafaxine in the treatment of major depressive disorder
Maria Teresa C Lourenco1, Sidney H Kennedy1,21Department of Psychiatry, University Health Network, Toronto; 2Department of Psychiatry, University of Toronto, Toronto, CanadaAbstract: Major depressive disorder (MDD) is among the most incapacitating conditions in the world. The emergence of the select...
Main Authors: | Maria Teresa C Lourenco1, Sidney H Kennedy1,2 |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-02-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/desvenlafaxine-in-the-treatment-of-major-depressive-disorder-a2877 |
Similar Items
-
Periodontal status in chronic periodontitis depressed patients on desvenlafaxine: An observational study
by: Anu Bhatia, et al.
Published: (2018-01-01) -
Efficacy and safety of escitalopram versus desvenlafaxine in the treatment of major depression: A preliminary 1-year prospective randomized open label comparative trial
by: Brij Mohan Gupta, et al.
Published: (2016-01-01) -
Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
by: Uml, et al.
Published: (2012-07-01) -
Serotonin-norepinephrine reuptake inhibitor desvenlafaxine for the treatment of interferon alfa-associated depression in patients with hepatitis C
by: Bruno Fábregas, et al.
Published: (2014-04-01) -
Venlafaxine and desvenlafaxine in the management of menopausal hot flashes
by: Johnson ED, et al.
Published: (2011-09-01)